DISCOVERY OF ANTITOXINS AND DEVELOPMENT OF ANTIBODY PREPARATIONS FOR CLINICAL USES FROM 1890 TO 1990

被引：29

作者：

GRONSKI, P ^{[1
]}

SEILER, FR ^{[1
]}

SCHWICK, HG ^{[1
]}

机构：

[1] BEHRINGWERKE AG,IMMUNOL RES DEPT,RES LABS,POB 1140,W-3550 MARBURG,GERMANY

来源：

MOLECULAR IMMUNOLOGY | 1991年 / 28卷 / 12期

关键词：

D O I：

10.1016/0161-5890(91)90034-H

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：1321 / 1332

页数：12

共 108 条

[1]

ALVING BM, 1980, J LAB CLIN MED, V96, P334

[2] HYPOTENSION ASSOCIATED WITH PREKALLIKREIN ACTIVATOR (HAGEMAN-FACTOR FRAGMENTS) IN PLASMA-PROTEIN FRACTION [J].

ALVING, BM ;

HOJIMA, Y ;

PISANO, JJ ;

MASON, BL ;

BUCKINGHAM, RE ;

MOZEN, MM ;

FINLAYSON, JS .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (02) :66-70

[3]

ARLT HG, 1940, MUNCHEN MED WOCHEN, V26, P696

[4]

BACH JF, 1975, MODE ACTION IMMUNOSU

[5] CLINICAL TOLERANCE AND CATABOLISM OF PLASMIN-TREATED GAMMA-GLOBULIN FOR INTRAVENOUS APPLICATION [J].

BARANDUN, S ;

CASTEL, V ;

MAKULA, MF ;

MORELL, A ;

PLAN, R ;

SKVARIL, F .

VOX SANGUINIS, 1975, 28 (03) :157-175

[6] INTRAVENOUS ADMINISTRATION OF HUMAN GAMMA-GLOBULIN [J].

BARANDUN, S ;

JEUNET, F ;

KISTLER, P ;

ISLIKER, H .

VOX SANGUINIS, 1962, 7 (02) :157-&

[7]

BARANDUN S, 1961, HELV MED ACTA, V28, P551

[8]

BARANDUN S, 1960, TAGUNG SCHWEIZ

[9]

BARANDUN S, 1961, VORTRAG TAGUNG PROTE

[10]

BARANDUN S, 1964, BIBL HAEMATOL, V17, P35

← 1 2 3 4 5 6 7 8 9 10 →